RaySearch Laboratories AB (publ) Interim Report January 1 – March 31, 2015
JANUARY 1 – MARCH 31, 2015 · Net sales for the period amounted to SEK 87.7 M (54.0) · Profit after tax totaled SEK 25.0 M (5.9) and earnings per share were SEK 0.73 (0.17) · Operating profit amounted to SEK 33.1 M (6.2) · Cash flow was SEK 7.8 M (neg: 3.4) · Order intake excluding service agreements amounted to SEK 86.3 M (54.8), of which RayStation® accounted for SEK 69.1 M (34.7) · RayStation® order backlog totaled SEK 30.6 M (61.0) · First proton therapy treatments with RayStation® in Europe · Sales and service company formed in Singapore for Asian market
Read original